Font Size: a A A

Clnicopathological Factoes Influencing Recurrence And Metastasis In Resceted Stage IB Nsclc

Posted on:2022-06-01Degree:MasterType:Thesis
Country:ChinaCandidate:H M ShiFull Text:PDF
GTID:2504306533958049Subject:Clinical Medicine
Abstract/Summary:PDF Full Text Request
Background: The prognosis of resected IB non-small cell lung cancer is still not ideal,and the administration of adjuvant chemotherapy is controversial.This study aims to investigate the prognostic value of clinicopathological factors and effect of adjuvant chemotherapy(ACT)in patients with resected IB non-small cell lung cancer.Methods: Patients with stage IB lung adenocarcinoma who received curative surgical resection from 2014 to 2016 in our institution were included.The outcome of interests was recurrence-free survival(RFS).The effect clinicopathological factors on recurrence and metastasis were evaluated by Kaplan-Meier estimates and Cox regression analysis.Results: A total of 191 patients with stage IB lung adenocarcinoma,including 92 male and 99 females were identified.After a median follow-up of 50.8 months,48(25.1%)patients developed recurrence.Univariate analysis showed that gender,smoking status,diabetes mellitus,and solid/micropapillary components were associated with decreased RFS.Multivariate analysis revealed that diabetes mellitus and solid/micropapillary components were independent risk factors for poor RFS(diabetes mellitus: HR 2.488,95%CI 1.105-5.604,p=0.028;solid/micropapillary: HR,3.115,95%CI 1.727-5.639,p<0.001).Multivariate analysis including ACT and surgical methods consistently verified the deterioration effect of diabetes mellitus and solid/micropapillary,it also indicated that ACT failed to show benefit on RFS(HR,0.817,95%CI 0.442-1.509,p=0.518).Conclusion: Solid or micropapillary component and diabetes mellitus are associated with poor prognosis in patients with resected IB lung adenocarcinoma,and adjuvant chemotherapy fails to improve the prognosis.
Keywords/Search Tags:lung adenocarcinoma, recurrence-free survival, adjuvant chemotherapy, histological subtype
PDF Full Text Request
Related items
The Effect Of Postoperative Adjuvant Chemotherapy On Recurrence-free Survival In Patients With Stage Ⅱ Non-small Cell Lung Cancer
Application Of Machine Learning Methods For Evaluating Proliferation,metastasis And Prognosis In Lung Adenocarcinoma
Early Non-small Cell Lung Cancer Resection Analysis Of Risk Factors For Recurrence And Establishment Of Predictive Models
Relationship Between EGFR Mutation Status And Histological Subtype And Survival In The New Classification Of Lung Adenocarcinoma
The Effect Of Sarcopenia On The Compliance And Recurrence-free Survival Of Adjuvant Chemotherapy After Radical Gastric In Patients With Gastric Cancer
Influences Of EGFR Or KRAS Gene Mutation Status On The Efficacy Of Postoperative Chemotherapy In Stageâ… B To â…¢A Lung Adenocarcinoma Patients By Pemetrexed Combined With Platinum Adjuvant Chemotherapy
Retrospective Analysis Of The Effect Of Combining Chemotherapy With The Fuzheng Quxie Formula On Disease-free Survival Of Patients After Radical Lung Adenocarcinoma Surgery
MSCT Quantitative Parameter Analysis And Histological Subtype Control Of Mixed Ground-glass Nodules Lung Adenocarcinoma
Biomarkers For Predicting Postoperative Prognosis And Chemotherapeutic Benefits In Resectable Gastric Cancer Patients Based On The Standardized Cohorts
10 1.Analysis Of The Influence Of Vascular Invasion On Postoperative Recurrence-free Survival In Patients With Stage PT1N0M0 Lung Adenocarcinoma 2.Mechanism Of Wild-type IDH1-FXR1-PSAT1-serine/glycine De Novo Synthesis Pathway To Maintain Non-small Cell Lung